Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 9801–9850 of 75567
In connection with Mr. Shoun’s return to his full responsibilities, Carson Heagan, the Company’s Vice President of Operations, who temporarily assumed the role of Chief Operating Officer, has ceased serving in that capacity.
he has resigned from the chairman and chief executive officer positions effective at the conclusion of the 2025 Annual Meeting
the board appointed Mr. Whelan (i) as president of the company effective April 1, 2025
as chief executive officer of the company effective at the conclusion of the 2025 Annual Meeting
provided that he is elected as a director at the 2025 Annual Meeting, as chairman of the board effective at the conclusion of such meeting
On February 12, 2025, Peter Quigley, the President and Chief Executive Officer of Kelly Services, Inc. (the “Company”), informed the Company's Board of Directors of his intention to retire as an officer in 2025 upon appointment of his successor.
Adam L. Metz has been promoted to Senior Executive Vice President and Chief Operating Officer of the Company and its subsidiary bank, Orrstown Bank (the 'Bank'), effective immediately
with the intent for him to succeed Thomas R. Quinn, Jr. as President and Chief Executive Officer of the Company and the Bank upon Mr. Quinn’s retirement on May 25, 2026.
John A. Ross informed the Company of his intention to retire from the Board of Directors (the “Board”) of the Company, effective as of the close of business on May 22, 2025.
On February 10, 2025, George E. Kilguss III, Executive Vice President and Chief Financial Officer of VeriSign, Inc. (the “Company”), informed the Company’s Board of Directors (the “Board”) of his intention to retire, effective May 31, 2025.
The Board has appointed John D. Calys, the Company’s Senior Vice President, Global Controller and Chief Accounting Officer, to succeed Mr. Kilguss upon the date of Mr. Kilguss’ retirement.
appointed Scott W. Madison as a member of the boards of directors, effective immediately
On February 12, 2025, upon the recommendation of its Corporate Governance and Nominating Committee, the Board of Directors (the “Board”) of Sonoco Products Company (the “Company”) approved an increase to the size of the Board from eleven (11) to twelve (12) directors and appointed Scott A. Clark to the Board.
Todd Foley, Kroger’s Interim Chief Financial Officer, will continue in that role until April 3, 2025, following which Mr. Foley will remain a Senior Vice President of the Company and continue to serve on the senior leadership team to support the Company until his retirement at the end of first quarter.
On February 12, 2025, The Kroger Co. (“Kroger” or the “Company”) appointed David Kennerley, 51, as Senior Vice President and Chief Financial Officer, effective as of April 3, 2025.
each member of the Company’s board of directors resigned from and ceased serving
each member of the Company’s board of directors resigned from and ceased serving
Mr. Callini’s employment will terminate as of August 14, 2025.
William Wise became the sole director of the Company, effective as of the Effective Time.
each member of the Company’s board of directors resigned from and ceased serving
each member of the Company’s board of directors resigned from and ceased serving
each member of the Company’s board of directors resigned from and ceased serving
On February 10, 2025, Dianne S. Mills, Senior Vice President and Chief Human Resources Officer, notified Acuity Brands, Inc. (the "Company") of her intent to retire from her current role with the Company effective December 31, 2025.
On February 11, 2025, Connie L. Matsui, a member of the Board of Directors of Halozyme Therapeutics, Inc. (the “Company”), notified the Company of her intention not to stand for reelection at the Company’s 2025 annual meeting of stockholders.
the Company appointed David Liu, the Lead Investor Nominee, to serve on the Board of Directors
On February 10, 2025, David P. Schenkein, M.D., notified Agios Pharmaceuticals, Inc. (the “Company”) of his decision to resign from the Board of Directors of the Company (the “Board”), effective February 28, 2025.
On February 10, 2025, Michael A. Perry resigned as a director of Nuveen Global Cities REIT, Inc. (the “Company”), effective immediately.
On February 13, 2025, Keith A. Jones resigned from his position as an officer of the Company, effective immediately.
On February 13, 2025, Hanesbrands Inc. (the “Company”) announced that Stephen B. Bratspies, its Chief Executive Officer, would be departing the Company at the end of 2025.
On February 13, 2025, Karl G. Glassman, the Company’s President and Chief Executive Officer, ceased serving as the acting, temporary segment manager of the Company’s Specialized Products segment.
On this same date, the Company appointed R. Samuel Smith, Jr. to serve as President of the Specialized Products segment.
Joshua Pinto, Ph.D. will transition from the role of Chief Financial Officer to President
Henry Gosebruch will depart the Company and no longer serve as President, Chief Executive Officer or a member of the Board.
Carol Suh will transition from the role of Chief Operating Officer to Chief Strategy Officer
Bill Aurora, Pharm.D. will transition from the role of Chief Strategy Officer to Chief Operating and Development Officer
Jason Duncan will serve as Chief Legal and Administrative Officer
Kaya Pai Panandiker will depart the Company and no longer serve as Chief Commercial Officer.
Michael Milligan will serve as Chief Financial Officer in addition to his current role as principal accounting officer
Paul L. Berns, the Company’s Co-Founder and Executive Chairman of its Board of Directors (the “Board”), will transition to the roles of Chief Executive Officer and Chairman of the Board
On February 12, 2025, Elizabeth (Libby) Spencer informed the Board of Directors (the “Board”) of Willamette Valley Vineyards, Inc. (the “Company”) that she was resigning from the Board effective February 13, 2025, for personal reasons.
Mr. Niel Ransom has been elected as a Class II director of the Company, effective February 1, 2025
On December 31, 2024, Chris Homeister, independent Director of our Company, provided written notice to the Company’s Board of his resignation, effectively immediately.
appointed Helle Thorning-Schmidt and Ralph Hamers to the Board
appointed Helle Thorning-Schmidt and Ralph Hamers to the Board
On February 7, 2025, Mistras Group, Inc. (the "Company") terminated the employment of its Executive Vice President, and President of Services, John Smith.
On February 7, 2025, LeMaitre Vascular, Inc. (the “Company”) agreed to terms with Dorian LeBlanc to become the Chief Financial Officer and principal financial officer of the Company, effective on March 10, 2025.
Michael Noble resigned his positions as President, Chief Executive Officer, Chief Financial Officer, Secretary and Treasurer of the Company, but remains as a director.
Neville Joanes was appointed director.
Brian Johnston was appointed President, Chief Executive Officer, President, Secretary and Treasurer and director of the Company
Effective as of February 5, 2025, the Company’s Board of Directors appointed Scott Harvey, age 63, as the Company’s President and Chief Executive Officer, replacing Paul Norman, who had served as Interim Chief Executive Officer since October 25, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.